← Browse by Condition
Medical Condition

venous thromboembolism

Total Trials
8
Recruiting Now
8
Trial Phases
Phase 3

ClinicalMetric tracks all active clinical trials for venous thromboembolism sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — venous thromboembolism Clinical Trials

How many clinical trials are currently recruiting for venous thromboembolism?
ClinicalMetric currently tracks 8 actively recruiting clinical trials for venous thromboembolism, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 8. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for venous thromboembolism?
venous thromboembolism research spans Phase 3 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a venous thromboembolism clinical trial?
Eligibility criteria for venous thromboembolism trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 3
1
Top Sponsors
Beijing Chao Yang Hospital 1 trial
Chinese University of Hong Kong 1 trial
University Hospital, Angers 1 trial
Danderyd Hospital 1 trial
GUALTIERO PALARETI 1 trial

Recruiting Clinical Trials

NCT06950697
Recruiting
Development and Application of a Thrombosis Risk Prediction Model in Lung Cancer Patients Treated With Immune Checkpoint Inhibitors
Enrollment
2,400 pts
Location
China
Sponsor
Beijing Chao Yang Hospital
View Trial →
NCT05378035
Recruiting
DOAC in Chinese Patients With Atrial Fibrillation
Enrollment
427 pts
Location
Hong Kong
Sponsor
Chinese University of Hong Kon...
View Trial →
NCT06195540 Phase 3
Recruiting
RIVAroxaban Versus Low-molecular Weight Heparin in Patients With Lower Limb Trauma Requiring Brace or CASTing
Enrollment
1,424 pts
Location
France
Sponsor
University Hospital, Angers
View Trial →
NCT03781531
Recruiting
Identification of Novel Biomarkers to Aid in the Detection of Occult Cancer in Patients With Venous Thromboembolism
Enrollment
1,000 pts
Location
Sweden
Sponsor
Danderyd Hospital
View Trial →
NCT02219984
Recruiting
START-Register: Survey on Anticoagulated Patients Register
Enrollment
15,410 pts
Location
Italy
Sponsor
GUALTIERO PALARETI
View Trial →
NCT07350499
Recruiting
Aspiration Thrombectomy Using the Symphony or Prodigy System
Enrollment
750 pts
Location
United States
Sponsor
Imperative Care, Inc.
View Trial →
NCT05756244
Recruiting
PRospective Evaluation of Peripartum Anticoagulation ManaGement for ThrOmboembolism
Enrollment
825 pts
Location
United States, Canad...
Sponsor
University of Calgary
View Trial →
NCT05881798
Recruiting
Post-Market Celect Platinum Vena Cava Filter and Gunther Tulip Retrieval Set Study
Enrollment
82 pts
Location
United States, Spain...
Sponsor
Cook Research Incorporated
View Trial →

Related Conditions

arterial thromboembolism (3) pulmonary embolism (3) atrial fibrillation (2) deep vein thrombosis (2) lung cancer (1) immune checkpoint inhibitors icis (1) stroke (1) stroke acute (1) brain diseases (1) major adverse cardiovascular event (1) lower limb trauma (1) thromboprophylaxis (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology